Integrin beta‐like 1 is regulated by DNA methylation and increased in heart failure patients

Author:

Kerrigan Lauren1ORCID,Edgar Kevin1,Russell‐Hallinan Adam1,Cappa Oisin1,Glezeva Nadezhda2,Galan‐Arriola Carlos3,Oliver Eduardo3,Ibanez Borja3,Baugh John2,Collier Patrick4,Ledwidge Mark2,McDonald Ken2,Simpson David1,Das Sudipto5,Grieve David J.1,Watson Chris J.1

Affiliation:

1. Wellcome‐Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK

2. UCD Conway Institute and Research and Innovation Programme for Chronic Disease, School of Medicine University College Dublin Dublin Ireland

3. Centro Nacional de Investigaciones Cardiovasculares (CNIC) Madrid Spain

4. Department of Cardiovascular Medicine Cleveland Clinic Cleveland Ohio USA

5. Royal College of Surgeons Dublin Ireland

Abstract

AbstractAimsDynamic alterations in cardiac DNA methylation have been implicated in the development of heart failure (HF) with evidence of ischaemic heart disease (IHD); however, there is limited research into cell specific, DNA methylation sensitive genes that are affected by dysregulated DNA methylation patterns. In this study, we aimed to identify DNA methylation sensitive genes in the ischaemic heart and elucidate their role in cardiac fibrosis.MethodsA multi‐omics integrative analysis was carried out on RNA sequencing and methylation sequencing on HF with IHD (n = 9) versus non‐failing (n = 9) left ventricular tissue, which identified Integrin beta‐like 1 (ITGBL1) as a gene of interest. Expression of Itgbl1 was assessed in three animal models of HF; an ischaemia‐reperfusion pig model, a myocardial infarction mouse model and an angiotensin‐II infused mouse model. Single nuclei RNA sequencing was carried out on heart tissue from angiotensin‐II infused mice to establish the expression profile of Itgbl1 across cardiac cell populations. Subsequent in vitro analyses were conducted to elucidate a role for ITGBL1 in human cardiac fibroblasts. DNA pyrosequencing was applied to assess ITGBL1 CpG methylation status in genomic DNA from human cardiac tissue and stimulated cardiac fibroblasts.ResultsITGBL1 was >2‐fold up‐regulated (FDR adj P = 0.03) and >10‐fold hypomethylated (FDR adj P = 0.01) in human HF with IHD left ventricular tissue compared with non‐failing controls. Expression of Itgbl1 was up‐regulated in three isolated animal models of HF and showed conserved correlation between increased Itgbl1 and diastolic dysfunction. Single nuclei RNA sequencing highlighted that Itgbl1 is primarily expressed in cardiac fibroblasts, while functional studies elucidated a role for ITGBL1 in cardiac fibroblast migration, evident in 50% reduced 24 h fibroblast wound closure occurring subsequent to siRNA‐targeted ITGBL1 knockdown. Lastly, evidence provided from DNA pyrosequencing supports the theory that differential expression of ITGBL1 is caused by DNA hypomethylation.ConclusionsITGBL1 is a gene that is mainly expressed in fibroblasts, plays an important role in cardiac fibroblast migration, and whose expression is significantly increased in the failing heart. The mechanism by which increased ITGBL1 occurs is through DNA hypomethylation.

Funder

Heart Research UK

British Heart Foundation

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3